News
In this pilot episode of the Applied Clinical Trials Brief, we examine the renewed push for placebo-controlled vaccine trials ...
WASHINGTON, DC – Dr. Vinay Prasad, the polarizing official who led U.S. vaccine oversight under the Trump administration, has stepped down from his position at the Food and Drug Administration (FDA) ...
23hon MSN
Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure.
23h
Verywell Health on MSNWhat to Know About COVID Vaccine This FallThere have been lots of changes to COVID vaccine recommendations. Here is the current vaccine schedule for people 6 months to 65+ years old.
The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...
In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...
22h
Zacks Investment Research on MSNNovavax (NVAX) Sees a More Significant Dip Than Broader Market: Some Facts to KnowNovavax (NVAX) ended the recent trading session at $6.85, demonstrating a -2.28% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.13%. At the same time, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results